Cornerstone Advisory’s Abiomed Inc ABMD Stock Holding History

Cornerstone Advisory’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150	Closed	-$54K	–	856
2021 Q4	$54K	Buy	+150	New	+$50.7K	0.01%	409

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cornerstone Advisory's ABMD Position: Q1 2022 in Review

Cornerstone Advisory sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 150 shares — an estimated $54K sold.

Cornerstone Advisory first reported a position in ABMD in Q4 2021 and held it in 1 quarter. The position peaked at $54K in Q4 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

Cornerstone Advisory reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
Cornerstone Advisory sold 150 Abiomed Inc shares in Q1 2022, an estimated $54K.
Cornerstone Advisory first reported a position in Abiomed Inc in Q4 2021 and held it in 1 quarter.
Cornerstone Advisory's Abiomed Inc position peaked at $54K in Q4 2021.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.